What is the share price of Abate AS Industries Ltd (ABATEAS) today?
The share price of ABATEAS as on 31st July 2026 is ₹9.61. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Abate AS Industries Ltd (ABATEAS) share?
The past returns of Abate AS Industries Ltd (ABATEAS) share are- Past 1 week: -2.54%
- Past 1 month: -3.90%
- Past 3 months: -9.35%
- Past 6 months: -18.61%
- Past 1 year: -62.71%
- Past 3 years: -3.29%
- Past 5 years: 110.29%
What are the peers or stocks similar to Abate AS Industries Ltd (ABATEAS)?
The peers or stocks similar to Abate AS Industries Ltd (ABATEAS) include:What is the market cap of Abate AS Industries Ltd (ABATEAS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abate AS Industries Ltd (ABATEAS) is ₹148.15 Cr as of 31st July 2026.What is the 52 week high and low of Abate AS Industries Ltd (ABATEAS) share?
The 52-week high of Abate AS Industries Ltd (ABATEAS) is ₹26.20 and the 52-week low is ₹8.What is the PE and PB ratio of Abate AS Industries Ltd (ABATEAS) stock?
The P/E (price-to-earnings) ratio of Abate AS Industries Ltd (ABATEAS) is 12.04. The P/B (price-to-book) ratio is 0.80.Which sector does Abate AS Industries Ltd (ABATEAS) belong to?
Abate AS Industries Ltd (ABATEAS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Abate AS Industries Ltd (ABATEAS) shares?
You can directly buy Abate AS Industries Ltd (ABATEAS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Abate AS Industries Ltd
ABATEAS Share Price
BSE₹9.610.10% (+0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ABATEAS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ABATEAS Performance & Key Metrics
ABATEAS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 12.05 | 0.80 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.85 | 6.02 | 0.50% |
ABATEAS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ABATEAS Company Profile
Abate AS Industries Ltd operates eye hospitals and optical stores, providing healthcare services and educational institutions in Kerala and Tamil Nadu, focusing on medical training and equipment.
PE Ratio
42.99
42.99
1Y Return
16.50%
16.50%
Buy Reco %
87.50
87.50
POLYMED
PE Ratio
53.55
53.55
1Y Return
12.17%
12.17%
Buy Reco %
75.00
75.00
FISCHER
PE Ratio
82.54
82.54
1Y Return
59.53%
59.53%
Buy Reco %
0.00
0.00
TARSONS
PE Ratio
116.89
116.89
1Y Return
13.97%
13.97%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
40.52
40.52
1Y Return
3.89%
3.89%
Buy Reco %
0.00
0.00
ABATEAS Sentiment Analysis
ABATEAS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ABATEAS Stock Summary · June 2026
Platform scaling drove a clear financial inflection in FY2026, with consolidated revenue rising to approximately Rs.161.7–161.8 crore and profit after tax expanding to about Rs.12.3 crore as management described the year as validation that the full operating platform is now visible in reported results. Management spoke with measured confidence, prioritizing a strategic shift to a healthcare‑led model—healthcare today is roughly 22% of revenue and is being grown for its higher margins and operating leverage—while also highlighting operational momentum in patient volumes, utilization and procedure intensity across Chennai and Kerala and the stabilizing cash generation from retail and the education talent pipeline. They acknowledged tensions from increased trade receivables and working‑capital pressure as the healthcare platform scales and noted ongoing investments that require disciplined capital allocation. Management signaled a focused approach to capacity expansion, collections improvement and selective, financially attractive M&A while keeping the balance sheet strong, and reiterated a multi‑year EBITDA target in the high‑teens (18–20%) with an expectation of around an ~18% level in the coming years.
ABATEAS Stock Growth Drivers
ABATEAS Stock Growth Drivers
4Material Financial Inflection and Improved Cash Conversion
FY2026 represented a clear financial inflection: consolidated revenue rose roughly 67% year‑on‑year to about Rs.161.7–161.8
Healthcare Momentum and Clear Path to Scale
The healthcare business is exhibiting tangible operational momentum with rising patient volumes, increased procedure growth,
ABATEAS Stock Challenges
ABATEAS Stock Challenges
2Highly fragmented regional market limiting scale and pricing power
The eye-care market remains highly fragmented across regional markets, creating significant barriers to achieving scale,
Rising trade receivables and working-capital strain as platform scales
Trade receivables increased as the healthcare platform expanded, driven in large part by elongated TPA
ABATEAS Forecast
ABATEAS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ABATEAS
ABATEAS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ABATEAS Income Statement
ABATEAS Income Statement
Quarterly Normal View
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 15.05 | 41.57 | 43.26 | 42.75 | 34.48 | ||||||||
Operating & Other expenses | 0.04 | 0.03 | 0.02 | 13.27 | 38.56 | 38.28 | 38.76 | 30.84 | ||||||||
EBITDA | -0.04 | -0.03 | -0.02 | 1.78 | 3.01 | 4.98 | 3.99 | 3.64 | ||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.55 | 0.49 | 0.52 | 0.52 | 0.52 | ||||||||
| PBIT | -0.04 | -0.03 | -0.02 | 1.23 | 2.52 | 4.46 | 3.47 | 3.12 | ||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.17 | 0.15 | 0.13 | ||||||||
| PBT | -0.04 | -0.03 | -0.02 | 1.17 | 2.41 | 4.29 | 3.32 | 2.99 | ||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | -0.02 | 0.16 | 0.22 | 0.28 | 0.06 | ||||||||
| Net Income | -0.04 | -0.03 | -0.02 | 1.19 | 2.25 | 4.07 | 3.04 | 2.93 | ||||||||
| EPS | -0.04 | -0.03 | -0.03 | 0.12 | 0.05 | 0.19 | 0.13 | 0.13 |
ABATEAS Company Updates
ABATEAS Stock Peers
ABATEAS Past Performance & Peer Comparison
ABATEAS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Abate AS Industries Ltd | 12.04 | 0.80 | — |
| Inventurus Knowledge Solutions Ltd | 42.99 | 17.33 | — |
| Poly Medicure Ltd | 53.55 | 6.24 | 0.21% |
| Fischer Medical Ventures Ltd | 82.54 | 7.58 | 1.25% |
ABATEAS Stock Price Comparison
Compare ABATEAS with any stock or ETFCompare ABATEAS with any stock or ETF
ABATEAS
ABATEAS Holdings
ABATEAS Shareholdings
ABATEAS Promoter Holdings Trend
ABATEAS Promoter Holdings Trend
ABATEAS Institutional Holdings Trend
ABATEAS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ABATEAS Shareholding Pattern
ABATEAS Shareholding Pattern
ABATEAS Shareholding History
ABATEAS Shareholding History
Foreign Institutions
smallcases containing ABATEAS stock
smallcases containing ABATEAS stock
Looks like this stock is not in any smallcase yet.
ABATEAS Events
ABATEAS Events
ABATEAS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ABATEAS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ABATEAS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ABATEAS has not given any dividends in last 5 years
ABATEAS Dividends
ABATEAS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeABATEAS Stock News & Opinions
ABATEAS Stock News & Opinions
Articles & Videos
Earnings
Earnings
Abate As Industries consolidated net profit rises 146.22% in the March 2026 quarterNet profit of Abate As Industries rose 146.22% to Rs 2.93 crore in the quarter ended March 2026 as against Rs 1.19 crore during the previous quarter ended March 2025. Sales rose 140.88% to Rs 33.94 crore in the quarter ended March 2026 as against Rs 14.09 crore during the previous quarter ended March 2025. For the full year,net profit rose 1018.18% to Rs 12.30 crore in the year ended March 2026 as against Rs 1.10 crore during the previous year ended March 2025. Sales rose 1031.37% to Rs 159.41 crore in the year ended March 2026 as against Rs 14.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales33.9414.09 141 159.4114.09 1031 OPM %9.165.75 -8.145.18 - PBDT3.501.72 103 15.061.64 818 PBT2.991.17 156 13.011.09 1094 NP2.931.19 146 12.301.10 1018 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries to convene board meetingAbate As Industries will hold a meeting of the Board of Directors of the Company on 29 May 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Abate As Industries standalone net profit rises 1300.00% in the December 2025 quarterNet profit of Abate As Industries rose 1300.00% to Rs 0.28 crore in the quarter ended December 2025 as against Rs 0.02 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries announces board meeting dateAbate As Industries will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Abate As Industries reports standalone net profit of Rs 0.84 crore in the September 2025 quarterNet profit of Abate As Industries reported to Rs 0.84 crore in the quarter ended September 2025 as against net loss of Rs 0.03 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries to conduct board meetingAbate As Industries will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries to convene board meetingAbate As Industries will hold a meeting of the Board of Directors of the Company on 15 October 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Abate As Industries reports standalone net profit of Rs 0.13 crore in the June 2025 quarterNet profit of Abate As Industries reported to Rs 0.13 crore in the quarter ended June 2025 as against net loss of Rs 0.04 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries schedules board meetingAbate As Industries will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Abate As Industries to conduct AGMAbate As Industries announced that the 34th Annual General Meeting(AGM) of the company will be held on 14 July 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 4.85%
Pledged promoter holdings is insignificant